Fibrosis and liver inflammation are key regulators of α1-acid glycoprotein fucosylation
View ORCID ProfileCarlos Oltmanns, Birgit Bremer, Laura Kusche, Per Stål, Robin Zenlander, Jan Tauwaldt, Ingvar Rydén, Peter Påhlsson, Markus Cornberg, Heiner Wedemeyer
doi: https://doi.org/10.1101/2023.11.14.23298443
Carlos Oltmanns
1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School (MHH), Hannover, Germany
2Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH). Hannover, Germany
3Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155), Hannover Medical School, Hannover, Germany
4TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH). Hannover, Germany
Birgit Bremer
1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School (MHH), Hannover, Germany
3Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155), Hannover Medical School, Hannover, Germany
Laura Kusche
1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School (MHH), Hannover, Germany
Per Stål
6Department of Medicine, Huddinge, Karolinska Institutet; and Division of Hepatology, Department of Upper GI diseases, Karolinska University Hospital; Stockholm, Sweden
Robin Zenlander
7Department of Clinical Chemistry, Karolinska University Hospital; Department of Laboratory Medicine, Karolinska Institutet; and Department of Medicine, Huddinge, Karolinska Institutet; Stockholm, Sweden
Jan Tauwaldt
1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School (MHH), Hannover, Germany
2Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH). Hannover, Germany
3Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155), Hannover Medical School, Hannover, Germany
4TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH). Hannover, Germany
Ingvar Rydén
8Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
Peter Påhlsson
8Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
Markus Cornberg
1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School (MHH), Hannover, Germany
2Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH). Hannover, Germany
3Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155), Hannover Medical School, Hannover, Germany
4TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH). Hannover, Germany
5German Centre for Infection Research (DZIF), partner site Hannover-Braunschweig, Germany
Heiner Wedemeyer
1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School (MHH), Hannover, Germany
3Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155), Hannover Medical School, Hannover, Germany
5German Centre for Infection Research (DZIF), partner site Hannover-Braunschweig, Germany

Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted November 15, 2023.
Fibrosis and liver inflammation are key regulators of α1-acid glycoprotein fucosylation
Carlos Oltmanns, Birgit Bremer, Laura Kusche, Per Stål, Robin Zenlander, Jan Tauwaldt, Ingvar Rydén, Peter Påhlsson, Markus Cornberg, Heiner Wedemeyer
medRxiv 2023.11.14.23298443; doi: https://doi.org/10.1101/2023.11.14.23298443
Fibrosis and liver inflammation are key regulators of α1-acid glycoprotein fucosylation
Carlos Oltmanns, Birgit Bremer, Laura Kusche, Per Stål, Robin Zenlander, Jan Tauwaldt, Ingvar Rydén, Peter Påhlsson, Markus Cornberg, Heiner Wedemeyer
medRxiv 2023.11.14.23298443; doi: https://doi.org/10.1101/2023.11.14.23298443
Subject Area
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (727)
- Anesthesia (215)
- Cardiovascular Medicine (3126)
- Dermatology (265)
- Emergency Medicine (464)
- Epidemiology (13075)
- Forensic Medicine (14)
- Gastroenterology (868)
- Genetic and Genomic Medicine (4893)
- Geriatric Medicine (451)
- Health Economics (755)
- Health Informatics (3086)
- Health Policy (1109)
- Hematology (411)
- HIV/AIDS (973)
- Medical Education (457)
- Medical Ethics (121)
- Nephrology (502)
- Neurology (4664)
- Nursing (248)
- Nutrition (691)
- Oncology (2405)
- Ophthalmology (683)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (311)
- Palliative Medicine (88)
- Pathology (519)
- Pediatrics (1249)
- Primary Care Research (526)
- Public and Global Health (7231)
- Radiology and Imaging (1613)
- Respiratory Medicine (945)
- Rheumatology (462)
- Sports Medicine (403)
- Surgery (518)
- Toxicology (65)
- Transplantation (222)
- Urology (192)